Online inquiry

IVTScrip™ mRNA-Human ANAPC15, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK14869MR)

This product GTTS-WK14869MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ANAPC15 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001278485.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 25906
UniProt ID P60006
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANAPC15, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK14869MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK4030MR IVTScrip™ mRNA-Human Carboxypeptidase M, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA Carboxypeptidase M
GTTS-WK23040MR IVTScrip™ mRNA-Human ATAD3C, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ATAD3C
GTTS-WK17715MR IVTScrip™ mRNA-Human AGR3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AGR3
GTTS-WK25142MR IVTScrip™ mRNA-Human ATAT1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ATAT1
GTTS-WK22222MR IVTScrip™ mRNA-Human APOBEC3F, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA APOBEC3F
GTTS-WK14506MR IVTScrip™ mRNA-Human ALDH9A1, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ALDH9A1
GTTS-WK17530MR IVTScrip™ mRNA-Human ALOX12P2, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ALOX12P2
GTTS-WK0263MR IVTScrip™ mRNA-Human LIN2, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA LIN2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW